Far Side fans might recall a classic 1982 cartoon called “Cow Tools,” featuring a cow standing next to a jumble of strange objects—the joke being that cows don’t use tools. That’s why a pet Swiss ...
Soley Therapeutics has secured $200 million in series C funds, which the artificial-intelligence-enabled biotech plans to use to take its lead acute myeloid leukemia (AML) asset into the clinic. The ...
Intel will formally launch its first Core Ultra Series 3 laptop processors later this month, the company announced at its CES keynote today. Codenamed Panther Lake and targeted, at least for now, at ...
LONDON, Dec 18 (Reuters) - Zara has become the latest fast-fashion retailer to use AI to help create new images of real models in different outfits, speeding up the production process as part of an ...
In mid-December 2025, an image (archived) circulated online purportedly showing U.S. President Donald Trump using a walker as a mobility aid. Keith Edwards, a Democratic political strategist, posted ...
Function Health, a startup that offers lab testing and body scans for early disease detection, scored nearly $300 million in series B funding, boosting its valuation to $2.5 billion. Redpoint Ventures ...
From electronic health records and blood tests to the stream of data from wearable devices, the amount of health information people generate is accelerating rapidly. Yet, many users struggle to ...
Function Health — the platform that gives subscribers access to more than 160 different lab tests — closed a $298 million Series B funding round on Wednesday, bringing the startup’s valuation to $2.5 ...
Disney is planning to flood its streaming service, Disney+, with user-generated AI slop. During the company’s recent earnings call, Disney CEO Bob Iger said that the streaming service is “in the midst ...
From simple text generation to autonomously powering robotic arms on production lines, AI technology offers enterprises a kaleidoscope of new capabilities. So which aspects of AI advancement have ...
Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...